These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36338998)

  • 1. Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma.
    Xu Y; Wang C; Li S; Zhou H; Feng Y
    Front Genet; 2022; 13():975419. PubMed ID: 36338998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma.
    Yang X; Wang X; Sun X; Xiao M; Fan L; Su Y; Xue L; Luo S; Hou S; Wang H
    Front Genet; 2022; 13():972899. PubMed ID: 36160015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.
    Yan X; Wang N; Dong J; Wang F; Zhang J; Hu X; Zhao H; Gao X; Liu Z; Li Y; Hu S
    Front Mol Biosci; 2022; 9():966843. PubMed ID: 36060266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma.
    Wen J; Zhao W; Shu X
    Front Oncol; 2022; 12():1087762. PubMed ID: 36776374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
    Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
    Front Genet; 2022; 13():951239. PubMed ID: 36186436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
    Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
    Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
    Chen P; Han H; Wang X; Wang B; Wang Z
    Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cuproptosis-related lncRNA landscape for predicting the prognosis and aiding immunotherapy in lung adenocarcinoma patients.
    Sun X; Song J; Lu C; Sun X; Yue H; Bao H; Wang S; Zhong X
    Am J Cancer Res; 2023; 13(3):778-801. PubMed ID: 37034212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.
    Hou D; Tan JN; Zhou SN; Yang X; Zhang ZH; Zhong GY; Zhong L; Yang B; Han FH
    Front Genet; 2022; 13():969845. PubMed ID: 36105091
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of cuproptosis-related lncRNAs for prognosis and immunotherapy in glioma.
    Wang L; Li Y; Wang Y; Li J; Sun Y; Chen J; Wang Z
    J Cell Mol Med; 2022 Dec; 26(23):5820-5831. PubMed ID: 36317420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
    Feng A; He L; Chen T; Xu M
    Front Oncol; 2022; 12():957966. PubMed ID: 36106123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 18. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
    Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
    Front Genet; 2023; 14():1124439. PubMed ID: 36936439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.